TP53 and cancer: Specifically, our data revealed that treatment of cancer cells with FL118 results in the downregulation of Mcl-1, XIAP and cIAP2 in addition to survivin in a p53 status-independent manner, while FL118 treatment showed minimal effects on Bcl-2 and Bcl-XL (Fig. 5a–c).